Picking the right treatment can be difficult. Blood vessel-targeting drugs like bevacizumab, for example, are not beneficial to every patient. But, a new blood test can help doctors and patients decide.
"We will now look to further explore the potential of using a blood test to personalise treatment for ovarian cancer patients. Moving towards a more individualised treatment plan specific for each patient and their particular tumour is key to improving outcomes for patients while sparing those unlikely to benefit from potential side effects of therapy." Caroline Dive
Read more: manchester.ac.uk/discover/n...
What do you think?